| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.3B | $5.0B | $5.0B | $3.8B | $1.3B | — | — |
| Cost of Revenue | $3.2B | $3.2B | $3.2B | $3.0B | $2.6B | $2.8B | $2.4B | $2.2B |
| Gross Profit | $2.1B | $2.0B | $1.7B | $2.0B | $1.1B | $0.4B | $0.4B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.4B | $1.4B | $1.3B | $1.2B | $1.0B | $1.0B | $0.9B | $0.9B |
| Operating Income | $0.4B | $0.2B | $0.2B | $0.6B | $-0.3B | $0.2B | $0.3B | $0.3B |
| Net Income | $0.3B | $0.2B | $0.1B | $0.4B | $-0.2B | $0.0B | $0.1B | $0.1B |
| EPS (Basic) | $1.71 | $0.87 | $0.69 | $2.50 | $-1.26 | $0.03 | $0.53 | $0.30 |
| EPS (Diluted) | $1.68 | $0.86 | $0.64 | $2.03 | $-1.26 | $0.03 | $0.52 | $0.30 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B | $3.6B | $3.4B | $3.8B | $3.4B | $3.3B | $1.8B | $1.8B |
| Current Assets | $1.4B | $1.4B | $1.1B | $1.4B | $1.5B | $1.0B | $1.0B | $0.9B |
| Cash & Equivalents | $0.3B | $0.4B | $0.2B | $0.4B | $0.9B | $0.4B | $0.4B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.9B | $0.9B | $0.8B | $0.8B | $0.9B | $0.8B | $0.5B | $0.5B |
| Stockholders' Equity | $1.8B | $1.7B | $1.6B | $1.4B | $1.1B | $1.2B | $1.2B | $1.2B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ | FY 2016↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.6B | $0.4B | $0.3B | $0.2B | $0.4B | — | — |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.3B | $-0.6B | $-0.1B | $-0.2B | — | — |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.2B | $0.1B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.3B | $-0.1B | $-0.4B | $-0.1B | $0.4B | $-0.2B | — | — |